Clinical Trials Browser

Phase 1/2 × Carcinoma, Small Cell × etoposide phosphate × Clear all

NCT00537511 2019-11-19

A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administered in Conjunction With Cisplatin and Etoposide

Phase 1/2 Terminated

22 enrolled 13 charts

Carcinoma, Small Cell